Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Scambia

Showing results (311-320 of 551) with videos related to

Pageof 56
Sort By:
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|April 17, 2018
Influence of prenatal diagnosis of abnormally invasive placenta on maternal outcome: systematic review and meta-analysisD Buca, M Liberati, G Calì, et al.
International Journal of Cancer|May 28, 1993
Quercetin induces type-II estrogen-binding sites in estrogen-receptor-negative (MDA-MB231) and estrogen-receptor-positive (MCF-7) human breast-cancer cell linesG Scambia, F O Ranelletti, P B Panici, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|November 19, 2016
Outcome of monochorionic twin pregnancy with selective intrauterine growth restriction according to umbilical artery Doppler flow pattern of smaller twin: systematic review and meta-analysisD Buca, G Pagani, G Rizzo, et al.
British Journal of Cancer|February 1, 1995
Prognostic significance of interleukin 6 serum levels in patients with ovarian cancerG Scambia, U Testa, P Benedetti Panici, et al.
Haematologica|January 1, 1990
Rationale for very high-dose chemotherapy with peripheral blood stem cell support in advanced ovarian cancerP B Panici, G Scambia, G Baiocchi, et al.
Gynecologic Oncology|April 1, 1993
Type II estrogen-binding sites in human ovarian cancer: correlation with estrogen, progesterone, and epidermal growth factor receptorG Ferrandina, G Scambia, P Benedetti Panici, et al.
Cancer|March 15, 1990
Recombinant alpha-2b-interferon enhances the circulating levels of a 90-kilodalton (K) tumor-associated antigen in patients with gynecologic and breast malignanciesG Scambia, P B Panici, S Iacobelli, et al.
International Journal of Cancer|December 15, 1990
Type-II estrogen binding sites in a lymphoblastoid cell line and growth-inhibitory effect of estrogen, anti-estrogen and bioflavonoidsG Scambia, F O Ranelletti, P Benedetti Panici, et al.
American Journal of Obstetrics and Gynecology|January 1, 1993
Expression of ras oncogene p21 protein in normal and neoplastic ovarian tissues: correlation with histopathologic features and receptors for estrogen, progesterone, and epidermal growth factorG Scambia, L Catozzi, P B Panici, et al.
Gynecologic Oncology|July 14, 2015
Laparoscopic radical hysterectomy in cervical cancer as total mesometrial resection (L-TMMR): a multicentric experienceV Chiantera, G Vizzielli, A Lucidi, et al.
Pageof 56

Showing results (311-320 of 551) with videos related to

Sort By:
Pageof 56
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|April 17, 2018
Influence of prenatal diagnosis of abnormally invasive placenta on maternal outcome: systematic review and meta-analysisD Buca, M Liberati, G Calì, et al.
International Journal of Cancer|May 28, 1993
Quercetin induces type-II estrogen-binding sites in estrogen-receptor-negative (MDA-MB231) and estrogen-receptor-positive (MCF-7) human breast-cancer cell linesG Scambia, F O Ranelletti, P B Panici, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|November 19, 2016
Outcome of monochorionic twin pregnancy with selective intrauterine growth restriction according to umbilical artery Doppler flow pattern of smaller twin: systematic review and meta-analysisD Buca, G Pagani, G Rizzo, et al.
British Journal of Cancer|February 1, 1995
Prognostic significance of interleukin 6 serum levels in patients with ovarian cancerG Scambia, U Testa, P Benedetti Panici, et al.
Haematologica|January 1, 1990
Rationale for very high-dose chemotherapy with peripheral blood stem cell support in advanced ovarian cancerP B Panici, G Scambia, G Baiocchi, et al.
Gynecologic Oncology|April 1, 1993
Type II estrogen-binding sites in human ovarian cancer: correlation with estrogen, progesterone, and epidermal growth factor receptorG Ferrandina, G Scambia, P Benedetti Panici, et al.
Cancer|March 15, 1990
Recombinant alpha-2b-interferon enhances the circulating levels of a 90-kilodalton (K) tumor-associated antigen in patients with gynecologic and breast malignanciesG Scambia, P B Panici, S Iacobelli, et al.
International Journal of Cancer|December 15, 1990
Type-II estrogen binding sites in a lymphoblastoid cell line and growth-inhibitory effect of estrogen, anti-estrogen and bioflavonoidsG Scambia, F O Ranelletti, P Benedetti Panici, et al.
American Journal of Obstetrics and Gynecology|January 1, 1993
Expression of ras oncogene p21 protein in normal and neoplastic ovarian tissues: correlation with histopathologic features and receptors for estrogen, progesterone, and epidermal growth factorG Scambia, L Catozzi, P B Panici, et al.
Gynecologic Oncology|July 14, 2015
Laparoscopic radical hysterectomy in cervical cancer as total mesometrial resection (L-TMMR): a multicentric experienceV Chiantera, G Vizzielli, A Lucidi, et al.
Pageof 56